My Lords, many of the debates here take me back to 2012, and I look forward to the contribution from my former boss, the noble Lord, Lord Lansley. I want to speak in support of Amendment 75 in the name of my noble friend Lady Sheehan. She has laid the amendment out effectively and comprehensively. There has long been tension between those marketing and those purchasing proprietary medicines and generics. Clearly, where pharmaceutical companies invest in research and development they should be rewarded for that, but we also know how expert the industry is at claiming R&D when that is beyond what they have actually done.
This issue plays out in the NHS but also internationally, particularly in developing countries where basic medicines may not be affordable and dependence on generics is vital. As the noble Baroness, Lady Finlay, said, the pandemic has shown how important this is. It reinforces that we are all interlinked. An infection that affects the community in one part of the world is within days potentially spread worldwide. It is in all our interests that disease is countered everywhere, as well as that being the right thing to do.
As my noble friend Lady Sheehan said, Amendment 75 affirms the Government’s right to use internationally agreed safeguards to protect public health, including securing access to more affordable generic medicines. As she said, earlier FTAs often focused on tariffs and trade in goods, while in the past couple of decades FTAs have become more comprehensive. Of course, many such developments are welcome in terms of ensuring standards, as we have been discussing, but provisions can also inappropriately protect monopolistic business. As I have said, genuinely innovative companies have a case, but their role can be exploited. In recognition of this, the WTO’s TRIPS agreement included public health safeguards. These were reaffirmed in the 2001 Doha declaration. Protecting genuine innovation has therefore already been addressed by the WTO, and it is important that these proposals are taken forward. I look forward to hearing the Minister’s response.
5.15 pm